logo-white

Abacus Medicine Pharma Services and Laboratoires CTRS extend partnership to improve access to Orphacol® in Spain

CTRS and Abacus Medicine Pharma Services

Abacus Medicine Pharma Services and Laboratoires CTRS extend partnership to improve access to Orphacol® in Spain PRESS RELEASE Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic partnership that ensures continuous stock of Orphacol® in Spain. Furthermore, the partnership means improved delivery lead times for […]

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux

AddMedica and Abacus Medicine Pharma Services

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux Abacus Medicine Pharma Services (AMPS) and AddMedica are proud to announce the signing of a partnership agreement for the marketing and distribution of Siklos® in Benelux. PRESS RELEASE Siklos® 100mg and 1000mg film-coated tablets are indicated for the treatment […]

Abacus Medicine Pharma Services and Gen.Orph sign partnership agreement for the exclusive distribution of Miglustat Gen.Orph in Austria

Gen. Orph and Abacus Medicine Pharma Services sign partnership agreement

Abacus Medicine Pharma Services and Gen.Orph sign partnership agreement for the exclusive distribution of Miglustat Gen.Orph in Austria. Abacus Medicine Pharma Services (AMPS) and Gen.Orph are proud to announce the signing of a partnership agreement for the exclusive marketing and distribution of Miglustat Gen.Orph in Austria. PRESS RELEASE Miglustat Gen.Orph 100 mg hard capsules is […]

Abacus Medicine Pharma Services and Luye Pharma sign distribution agreement for Named Patient Program (NPP) of Lurbinectedin in Hong Kong

Abacus-Medicine-Pharma-Services-and-Luye-Pharma

Abacus Medicine Pharma Services and Luye Pharma sign distribution agreement for Named Patient Program (NPP) of Lurbinectedin in Hong Kong. Abacus Medicine Pharma Services (AMPS) and Luye Pharma Group are proud to announce the signing of an exclusive distribution contract to make Lurbinectedin available to small cell lung cancer patients in Hong Kong via the […]

Aposave rebrands to Abacus Medicine Pharma Services

ABACUS-MEDICINE-pharma-services-logo_RGB

New generation healthcare and pharma services company Aposave rebrands to Abacus Medicine Pharma Services. Abacus Medicine Pharma Services is the new name for the healthcare and pharma services company previously known as Aposave. PRESS RELEASE “The new brand makes it very clear who we are and what we do. The closer association with the Abacus […]

Aposave and CTRS enter strategic partnership

Aposave-and-CTRS-thumbnail

Aposave and Laboratoires CTRS enter strategic partnership The strategic partnership will drive awareness and treatment of Bile Acid Synthesis Disorders in the Benelux region. PRESS RELEASE Aposave Ltd and Laboratoires CTRS are proud to announce the signing of an exclusive contract to drive awareness and diagnosis of primary Bile Acid Synthesis Disorders (BASD) across the […]

Aposave’s Virtual Clinical Trial Congresses in 2021

Capture_CTSUSA_slide1_v2

The virtual CTS congresses of 2021 What do Silverstone, Clinical Trials, San Antonio (Texas), COVID-19, Madrid, Aposave and Burlingame (California) have in common? The answer is Ian Hoban! Well, virtually. Ian is the commercial lead for the Clinical Trial Solutions business unit of new generation healthcare and pharma services company – Aposave. Ian has close […]

Clinical Trial Comparator challenges in 2020

news-Happy-Patient

AMPS writes article for the Clinical Trial Supply Handbook 2021 In the article, Business Development Director, Ian Hoban, addresses the results of a recent clinical trial supplies survey, while highlighting the threat of the “COVID timebomb”. Survey results and the “COVID timebomb” In September 2020, the Aposave team attended the GCSG 2020 conference. Here, we […]

Webinar: Mitigating CTS costs post-COVID

Capture_CTSUSA_slide1_v2

Webinar: Mitigating CTS costs post-COVID According to information published by GlobalData, 1200 clinical trials were disrupted by COVID-19. In this webinar, Ian Hoban, Business Development Director (Clinical Trial Solutions), talks about the risks and the actions that can be implemented to avoid the “COVID Timebomb.” Simon Estcourt, Managing Director, and Warren Crawford, Corporate Development Director, […]